Current best practice in the management of neuroendocrine tumors
Neuroendocrine neoplasms are rare tumors that display marked heterogeneity with varying natural history, biological behavior, response to therapy and prognosis. Their management is complex, particularly as a number of them may be associated with a secretory syndrome and involve a variety of options....
Main Authors: | Marina Tsoli, Eleftherios Chatzellis, Anna Koumarianou, Dionysia Kolomodi, Gregory Kaltsas |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-01-01
|
Series: | Therapeutic Advances in Endocrinology and Metabolism |
Online Access: | https://doi.org/10.1177/2042018818804698 |
Similar Items
-
Anti-tumour activity of everolimus and sunitinib in neuroendocrine neoplasms
by: Kosmas Daskalakis, et al.
Published: (2019-05-01) -
Pancreatic Neuroendocrine Tumors Presenting with Hypercalcitonemia
by: Alexandra Chrisoulidou, MD, PhD, et al.
Published: (2015-01-01) -
Efficacy and Safety of First-Line Everolimus Therapy Alone or in Combination with Octreotide in Gastroenteropancreatic Neuroendocrine Tumors. A Hellenic Cooperative Oncology Group (HeCOG) Study
by: Anna Koumarianou, et al.
Published: (2020-03-01) -
Association of a Palliative Surgical Approach to Stage IV Pancreatic Neuroendocrine Neoplasms with Survival: A Systematic Review and Meta-Analysis
by: Marina Tsoli, et al.
Published: (2020-08-01) -
Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms
by: Krystallenia I. Alexandraki, et al.
Published: (2017-01-01)